Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8652)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2017 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papamichael K, Cheifetz AS. Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy. World J Gastroenterol 2017; 23(34): 6197-6200 [PMID: 28974885 DOI: 10.3748/wjg.v23.i34.6197] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i34/6197.htm |
| Number | Citing Articles |
| 1 |
C.R.H. Hedin, E. Sonkoly, M. Eberhardson, M. Ståhle. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach. Journal of Internal Medicine 2021; 290(2): 257 doi: 10.1111/joim.13282
|
| 2 |
Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos. The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials. Journal of Clinical Medicine 2022; 11(11): 3045 doi: 10.3390/jcm11113045
|
| 3 |
Jeroen Geldof, Nusrat Iqbal, Janindra Warusavitarne, Ailsa Hart. The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel Diseases: Combined Medical-Surgical Treatment in Complex Perianal Fistulas in CD. Clinics in Colon and Rectal Surgery 2022; 35(01): 021 doi: 10.1055/s-0041-1740035
|
| 4 |
Daniel J Wong, Eve M Roth, Joseph D Feuerstein, Vitaliy Y Poylin. Surgery in the age of biologics. Gastroenterology Report 2019; 7(2): 77 doi: 10.1093/gastro/goz004
|
| 5 |
Wan-Ting Cao, Rong Huang, Ke-Fang Jiang, Xue-Hui Qiao, Jing-Jing Wang, Yi-Hong Fan, Yi Xu. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(9): 886-907 doi: 10.3748/wjg.v27.i9.886
|
| 6 |
Jeroen Geldof, Nusrat Iqbal, Jean-Frédéric LeBlanc, Sulak Anandabaskaran, Rachel Sawyer, Christianne Buskens, Willem Bemelman, Krisztina Gecse, Lilli Lundby, Amy L Lightner, Silvio Danese, Antonino Spinelli, Michele Carvello, Omar Faiz, Janindra Warusavitarne, Phillip Lung, Danny De Looze, André D'Hoore, Séverine Vermeire, Ailsa Hart, Phil Tozer. Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials. The Lancet Gastroenterology & Hepatology 2022; 7(6): 576 doi: 10.1016/S2468-1253(22)00007-3
|
| 7 |
Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02676-9
|
| 8 |
Na Hong, Wei-Yong Liu, Jin-Long Zhang, Kai Qian, Jie Liu, Xian-Jun Ye, Fei-Yan Zeng, Yue Yu, Kai-Guang Zhang. Assessment of perianal fistulizing Crohn’s disease activity with endoanal ultrasound: A retrospective cohort study. World Journal of Gastrointestinal Surgery 2024; 16(8): 2494-2502 doi: 10.4240/wjgs.v16.i8.2494
Abstract(149) |
Core Tip(132) |
Full Article(HTML)(528)
|
Full Article with Cover (PDF)-1104K(29)
|
Full Article (Word)-151K(0)
|
Audio-612K(4)
|
Peer-Review Report-222K(15)
|
Answering Reviewers-2061K(16)
|
Full Article (PDF)-666K(32)
|
Full Article (XML)-105K(18)
|
Times Cited (0)
|
Total Visits (1390)
|
Open
|
| 9 |
Konstantinos Papamichael, Niels Vande Casteele, Jenny Jeyarajah, Vipul Jairath, Mark T. Osterman, Adam S. Cheifetz. Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis. American Journal of Gastroenterology 2021; 116(5): 1007 doi: 10.14309/ajg.0000000000001111
|